To the full analysis
Metrovacesa stock: growth
MVC.MCMetrovacesa reported $785.04M in revenue for fiscal 2025, up 8.4% on the prior year, up 38.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−0.7%
per year from 2004 to 2025, per share −4.8%
Earnings (Annual rate)
−6.9%
per year from 2004 to 2025, per share −29.8%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2004 | |
|---|---|---|---|
| Revenue | 38.3% | 34.7% | −0.7% |
| Revenue per share | 38.3% | 27.6% | −4.8% |
| Earnings | no data | −1.2% | −6.9% |
| Earnings per share | no data | −6.3% | −29.8% |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2004 | $904.11M | $242.67M | −$261.35M |
| 2005 | $1.27B | $677.97M | −$317.04M |
| 2006 | $1.66B | $1.99B | −$921.03M |
| 2007 | $1.01B | $1.41B | −$840.99M |
| 2008 | $802.02M | −$809.48M | $175.15M |
| 2009 | $635.49M | −$984.86M | $551.61M |
| 2010 | $421.12M | −$103.8M | $92.41M |
| 2011 | $275.16M | −$158.53M | $232.42M |
| 2012 | $230.23M | −$298.44M | $101.2M |
| 2015 | $39.93M | $71.08M | −$68.95M |
| 2016 | $23.29M | −$22.75M | $23.17M |
| 2017 | $31.24M | −$43.12M | −$30.22M |
| 2018 | $211M | −$10.09M | $37.59M |
| 2019 | $178.97M | −$4.98M | −$32.27M |
| 2020 | $154.95M | −$181.2M | −$87.35M |
| 2021 | $565.96M | $20.46M | $153.15M |
| 2022 | $575.33M | −$26.01M | $234.11M |
| 2023 | $649.86M | −$23.1M | $34.11M |
| 2024 | $724.43M | $17.6M | $105.22M |
| 2025 | $785.04M | $63M | $240.38M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.